This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2017-08-10 Patient Care FHIR Call"
Jump to navigation
Jump to search
Line 209: | Line 209: | ||
Patient Care WGM agenda: [[PC_Sept_2017_WGM]] | Patient Care WGM agenda: [[PC_Sept_2017_WGM]] | ||
− | Questions raised | + | Questions raised about |
* [https://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8458 GF#8458] Is a blood transfusion closer to a medication administration or a procedure, or something else? | * [https://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8458 GF#8458] Is a blood transfusion closer to a medication administration or a procedure, or something else? | ||
* [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12993 GF#12993] Please Create a NonMedicationAdministration object or an Administration object | * [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=12993 GF#12993] Please Create a NonMedicationAdministration object or an Administration object | ||
Line 216: | Line 216: | ||
** [https://chat.fhir.org/#narrow/stream/implementers/topic/Radiation.20therapy Radiology Therapy discussion on Zulip] | ** [https://chat.fhir.org/#narrow/stream/implementers/topic/Radiation.20therapy Radiology Therapy discussion on Zulip] | ||
** [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation on Zulip] | ** [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation on Zulip] | ||
+ | * [[2017-04-13_Patient_Care_FHIR_Call]] | ||
+ | ** NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material | ||
+ | ** It would include things like bone marrow, cord blood, peripheral blood stem cells - and any new resource could also address solid organs and blood transfusion although not part of the initial use case | ||
+ | ** Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”) | ||
+ | |||
SOAP / ClinicalImpression | SOAP / ClinicalImpression |
Revision as of 20:25, 10 August 2017
Contents
Meeting Information
Patient Care FHIR Resources Conference Call Location: Conference Call |
Date: 2017-08-10 Time: 5-6:30pm ET | ||
Facilitator | Michelle M Miller | Note taker(s) | Michelle M Miller |
Attendee | Name | Affiliation
| |
Elaine Ayres | NIH/Department of Clinical Research Informatics | ||
Dave Carlson | VA | ||
Stephen Chu | The Australian Digital Health Agency (ADHA) | ||
Evelyn Gallego | EMI Advisors LLC | ||
Eric Haas | Haas Consulting | ||
Rob Hausam | Hausam Consulting LLC | ||
Laura Heermann-Langford | Intermountain Healthcare | ||
Emma Jones | Allscripts | ||
Russ Leftwich | InterSystems | ||
Tony Little | Optum 360 | ||
Jay Lyle | Ockham Information Services LLC, VA | ||
Russell McDonell | Telstra Health | ||
Lloyd McKenzie | Gevity (HL7 Canada) | ||
Larry McKnight | Cerner | ||
Michelle M Miller | Cerner | ||
Lisa Nelson | Life Over Time Solutions | ||
Viet Nguyen | Lockheed Martin, Systems Made Simple | ||
M'Lynda Owens | Cognosante | ||
Mike Padula | The Children's Hospital of Philadelphia | ||
Craig Parker | Intermountain Healthcare | ||
Joe Quinn | Optum | ||
Simon Sum | Academy of Nutrition and Dietetics | ||
Iona Thraen | Dept of Veterans Affairs | ||
Serafina Versaggi | Dept of Veterans Affairs | ||
Buitendijk,Hans | Cerner | ||
JD Nolen | |||
Kenneth McCaslin | Accenture | ||
Lorraine Constable | |||
Patrick Loyd | |||
Riki Merrick | |||
Melva Peters | Gevity | ||
John Hatem | |||
Jean Duteau | |||
Scott Robertson | |||
Jose Costa Teixeira | |||
Grahame Grieve | |||
Quorum Requirements Met: yes |
Agenda
Agenda Topics
- Agenda review
- Approve previous meeting minutes 2017-08-03_Patient_Care_FHIR_Call
- Motion: <moved>/<seconded>
- OO/PC/Pharmacy Joint Discussion
Supporting Information
- Tracker Issues - https://docs.google.com/a/lmckenzie.com/uc?id=0B285oCHDUr09Mzh3b09rMFhEV1E
- Resolve QA Warnings to have resource FMM > 0
- Resolve QA Information messages to achieve FMM = 3
- Maintain QA checklist
Minutes
gForge Change Requests
Patient Care WGM agenda: PC_Sept_2017_WGM
Questions raised about
- GF#8458 Is a blood transfusion closer to a medication administration or a procedure, or something else?
- GF#12993 Please Create a NonMedicationAdministration object or an Administration object
- GF#12673 How to handle HCT/TP
- GF#13047 and GF#12966 Add DosageInstructions to Procedure/ProcedureRequest
- 2017-04-13_Patient_Care_FHIR_Call
- NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material
- It would include things like bone marrow, cord blood, peripheral blood stem cells - and any new resource could also address solid organs and blood transfusion although not part of the initial use case
- Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
SOAP / ClinicalImpression
- GF#12676 Guidance request for GP SOAP in FHIR (Alexander Henket) -
- https://chat.fhir.org/#narrow/stream/implementers/topic/ClinicalImpression
- PC, SD - possibly Thurs Q2
Adjourn
Adjourned at <hh:mm am/pm> <timezone>.
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2012 Health Level Seven® International. All rights reserved.